153 related articles for article (PubMed ID: 31845305)
1. Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns.
Nappi C; Zampella E; Volpe F; De Risi M; Piscopo L; Ponsiglione A; Imbriaco M; Acampa W; Petretta M; Cuocolo A
J Nucl Cardiol; 2020 Jun; 27(3):915-920. PubMed ID: 31845305
[TBL] [Abstract][Full Text] [Related]
2.
Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
4. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
5. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
[TBL] [Abstract][Full Text] [Related]
6. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
[TBL] [Abstract][Full Text] [Related]
8. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic imaging of cardiac amyloidosis.
Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
11. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
12. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
13. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
[TBL] [Abstract][Full Text] [Related]
14. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH
Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105
[TBL] [Abstract][Full Text] [Related]
15. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
[TBL] [Abstract][Full Text] [Related]
16. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
18. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
19. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
20. Nuclear imaging modalities for cardiac amyloidosis.
Bokhari S; Shahzad R; Castaño A; Maurer MS
J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]